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Herpes simplex virus type 1(HSV-1) L-particles are known to be composed mainly of envelope and tegument proteins, to
lack the nucleocapsid, and to be noninfectious. Thus L-particles represent interesting vaccine candidates. L-particles at
.1000/cell interfered with HSV-1 virion adsorption and penetration. While L-particles did not affect HSV-1 growth kinetics in
resting or nonresting BHK cultures infected with purified virions, treatment with L-particles before, or after, transfection with
HSV-1 DNA resulted in a progressive increase in plaque numbers (five- to sixfold at 1000 L-particles/cell). Transfection
assays using HSV-1 ts mutant DNA (ts1201) revealed that enhancement was due to induction of otherwise nonreplicating
genomes. The enhancement obtained with L-particles produced by WT HSV-1 or by mutants that are either deleted, or
defective, in certain gene products was compared. Most important were the Vmw110 (ICP0) and Vmw65 (a-TIF) proteins, but
VP11/12, VP13/14, and vhs also have a role. The L-particle-associated Vmw175 (ICP 4) protein did not appear be involved.
The effect of homologous and heterologous combinations of pseudorabies virus, equineherpesvirus-1, and HSV-1 DNA’s and
L-particles was investigated in transfection assays. The L-particles of each virus, to varying extent, enhanced the plaquing
efficiency of their own DNA but were also effective in heterologous combinations. © 1997 Academic Press
INTRODUCTION
The supernatant yield of herpes simplex virus type 1
(HSV-1, strain 17) from infected BHK cells can be sepa-
rated on Ficoll gradients into a narrow high-density band
containing virions and a broad low-density band contain-
ing light-particles (L-particles). Characteristically, L-par-
ticles are composed of the virus envelope and tegument
components, but lack the virus genome and all the pro-
teins of the capsid (Szilagyi and Cunningham, 1991).
Noninfectious L-particles are, therefore, interesting can-
didates for nucleic acid-free vaccine development. Sz-
ilagyi and Berriman (1994) have observed that most L-
particles have, in place of the virion capsid structure, one
or more smooth-membrane bound inclusion vesicles
embedded within the tegument and have suggested that
certain phosphoproteins may be associated with these.
These L-particle associated phosphoproteins (175K,
132K, 92K, 60K, and 55K Mr) have not been detected in
the virion (Szilagyi and Cunningham, 1991) and only the
identification of the IE transactivating protein (Vmw 175K,
gene RS1) has been reported (McLauchlan and Rixon,
1992).
Particles analogous to these L-particles have been
identified in the supernatant yield from several other
a-herpesvirus/cell systems, including: HSV-1 (strain F),
HSV-2 (HG52), equine herpesvirus-1 (EHV-1), and pseu-
dorabies virus (PRV) each grown in BHK cells
(McLauchlan and Rixon, 1992; A. MacLean, personal
communication), varicella-zoster virus (VZV) grown in
simian kidney fibroblasts (CV-1), and bovine herpesvi-
rus-1 (BHV-1) grown in bovine epithelial (MDBK) cells
(our unpublished observations). These observations
generate the expectation that during productive infection
of many cultured cell lines all members of the a-herpes-
virus family will normally yield both virions and L-parti-
cles. It is not known whether L-particles are made during
natural infection, but the finding that L-particles can be
isolated from HSV-1-infected human fetal lung fibroblasts
(Flow 2002) and human melanoma cells (MEWO) (Dar-
gan et al., 1995) makes this highly likely.
HSV-1 L-particles are biologically competent and can
deliver functional tegument proteins to target cells about
as efficiently as virions, hence L-particle envelope pro-
teins must be organized in a biologically effective ar-
rangement; the functional status of two HSV-1 L-particle
tegument proteins has been reported—both the Vmw
65K transinducing factor (a-TIF, UL48) and the virion host
shut-off protein Vmw 58K (vhs, UL41) were found to be
fully active (McLauchlan et al., 1992). The observation
that the amounts of a-TIF and vhs proteins contained
within a single HSV-1 virion was insufficient to elicit a
maximal response in an infected cell (Ace et al., 1989;
McLauchlan et al., 1992) prompted the suggestion that
L-particles might facilitate HSV-1 infection in vivo by
1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 144 141 337 2236. E-mail: D.Dargan@vir.gla.ac.uk.
VIROLOGY 239, 378–388 (1997)
ARTICLE NO. VY978893
0042-6822/97 $25.00
Copyright © 1997 by Academic Press
All rights of reproduction in any form reserved.
378
supplying additional quantities of proteins needed during
the initial rounds of replication (McLauchlan et al., 1992).
To gain insight into L-particle function and whether
L-particles play a facilitating role, we have studied their
effect on HSV-1 virion adsorption, penetration, and virus
replication, and on plaquing efficiency of transfected
herpesvirus DNAs.
MATERIALS AND METHODS
Cells
BHK-21 cells were propagated in Eagles medium sup-
plemented with 10% new-born calf serum (EC 10%).
Transfected cells and virus titrations were overlaid with
medium containing 5% serum (EC 5%) and 1.25% methyl-
cellulose.
Viruses
The wild-type (WT) viruses used were HSV-1 (strain
17), PRV, and EHV-1 (strain Ab4). Several mutants of
HSV-1 strain 17 were also used: in1814 an insertion
mutant in the UL48 gene reading frame that eliminates
a-TIF transinducing activity but retains the protein’s
structural role (Ace et al., 1988; 1989); DL1403 a mutant
lacking Vmw IE 110K, having the RL2 gene deleted (Stow
and Stow, 1986); FxE, a mutant without the zinc finger
motif of the IE 110K protein (Everett, 1989); 17(412), which
lacks the vhs gene UL41 (Fenwick and Everett, 1990); tsK
a mutant in gene RS1 which makes a temperature-sen-
sitive IE175K transactivating protein (Marsden et al.,
1976; Preston, 1981); and three HSV-1 (strain F) mutants
D46, D47, and D46/47 deleted in UL46, UL47, and both
UL46 and 47 genes, respectively (Zhang et al., 1991;
Zhang and McKnight, 1993).
L-particles and virions were purified as described by
Szilagyi and Cunningham (1991) and quantitated by elec-
tron microscope counting of negatively stained particles.
Such L-particle preparations are usually contaminated
with virions at levels between 1 and 5%. To eliminate
infectivity from contaminating virions, L-particle prepara-
tions were routinely treated in a Stratalinker (model 1800)
with 160 mJ/cm2 of 254-nm wavelength UV light; this had
little effect on the ability of L-particles to deliver tegument
proteins to cells (McLauchlan et al., 1992).
Adsorption assay
HSV-1 L-particles were adsorbed to the cell surface for
1 h at 4°C. After three PBS washes at 4°C, purified HSV-1
virions (106 PFU, particle:PFU, 20:1) were added to the
cells which were then maintained at 4°C. At various
times aliquots of the virus inoculum were removed and
the residual infectivity titrated.
Penetration assay
Confluent BHK cell monolayers precooled to 4°C were
infected with 100 PFU of purified HSV-1/monolayer (par-
ticle:PFU, 20:1) and allowed 1 h at 4°C to adsorb the
virus. After three cold PBS washes the monolayers were
treated with various L-particle concentrations for 1 h at
4°C. After further washing the cultures were shifted to
37°C to allow penetration. The rate of virion penetration
was monitored by inactivating nonabsorbed virions at
various times after infection by washing the infected
monolayers with (0.1 M glycine in 0.14 M-NaCl, pH 3.0) for
1 min (Rosenthal et al., 1984). The cell layers were then
overlaid with EC 5% containing methyl-cellulose, incu-
bated at 37°C for 48 h, and the resulting plaques were
fixed, stained, and counted.
HSV-1 Single-step and multistep growth
Confluent BHK monolayers (2 3 106 cells) were in-
fected with purified HSV-1 virions (particle:PFU, 20:1) at
multiplicities of 5 (single-step), 0.001, or 0.01 (multistep).
After 45 min adsorption at 37°C and three PBS washes
the cultures were exposed to various HSV-1 L-particle
concentrations for 45 min at 37°C, followed by three PBS
washes. Infected cultures were then overlaid with EC
10%, incubated at 37°C for various periods, harvested by
scraping into the medium, sonicated to release intracel-
lular virus, and titrated.
Transfection of herpesvirus DNAs
Near confluent monolayers of BHK cells were mock-
treated or treated with L-particles at different multiplici-
ties, adsorbed for 1 h at 37°C, and washed three times
with PBS. Herpesvirus DNA (titrated to give between 10
and 40 plaques/monolayer; 0.2 to 0.8 mg/monolayer) was
transfected into the cells by calcium phosphate precipi-
tation and 20% (vol/vol) dimethylsulfoxide (DMSO) boost
(Stow and Wilkie, 1976). After final washing and overlay-
ing with EC 5% containing 1.25% methyl-cellulose, fol-
lowed by 2 days incubation at 37°C, plaques were
counted. Appropriate controls lacking viral DNA or L-
particles or treated with wild-type L-particles were in-
cluded in each experiment which was performed in du-
plicate.
RESULTS
The effect of HSV-1 L-particles on virus entry
Initially, the effect of HSV-1 L-particles on the viability
of uninfected cells was studied. BHK monolayers on
24-well trays (2 3 105 cells/well) were treated with 100,
1,000, or 10,000 HSV-1 L-particles/cell. Cell viability, as
determined by trypan blue dye-exclusion (Dargan and
Subak-Sharpe, 1985) was estimated at 1, 2, or 3 days
after treatment. Even 3 days treatment with up to 10,000
L-particles/cell had little or no effect upon cell viability
(92% compared to 97% for control). Thus we can exclude
L-particle-mediated cell death or cytotoxicity from caus-
ing significant interference in subsequent experiments.
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However, 3 days treatment with 100, 1,000 and 10,000
L-particles/cell affected cell culture growth and resulted
in reductions in cell number of 12, 38, and 50%, respec-
tively, relative to the control. To minimize differences in
cell number due to L-particle treatment confluent cell
monolayers were used in all subsequent experiments.
In cultures treated with high numbers of L-particles the
growth reduction may be due to introduction of functional
vhs, other L-particle protein(s), or induction of a cellular
stress response. When investigating the latter no
polypeptide band corresponding to any recognized heat-
shock or glucose-regulated cellular stress protein were
detected (data not shown). We conclude that one or more
components of L-particles are responsible for the reduc-
tion in cell culture growth.
The effect of HSV-1 L-particles on the plaquing effi-
ciency of coinfecting virions was studied. Purified virions
(particle:PFU, 98:1), aliquoted to produce either 10 or 100
plaques/monolayer, were mixed with purified L-particles
to provide 0, 100, 1,000, 10,000 L-particles/cell. After ab-
sorption the monolayers were washed, overlaid with EC
10%, incubated at 37°C for 48 h, then fixed, stained, and
the plaques counted. Treatment with 100 L-particles/cell
had no effect, but plaque numbers progressively de-
creased in cultures treated with 1,000 and 10,000 L-
particles/cell to, respectively, 63 and 36% of control at 10
PFU/plate and 77 and 32% at 100 PFU/plate.
Impairment of HSV-1 plaquing might be caused by
interference during virus adsorption and/or penetration.
We tested this by HSV-1 adsorption and penetration
assays which make use of the observation that at 4°C
HSV-1 virions (and presumably HSV-1 L-particles) bind to
the plasma membrane but do not penetrate until the
temperature is raised (Farnham and Newton, 1959).
The effect of L-particles on adsorption of HSV-1 is
shown in Fig. 1A. In their absence 64% of the input virus
adsorbed to the cells in 120 min (the baseline 100%
control value). Treatment with 10 and 100 L-particles/cell
had little or no effect on virus adsorption, but 1,000 and
10,000 L-particles/cell reduced the number of virions
bound to the cells within 120 min to 70 and 55%, respec-
tively, of the control value. Thus high numbers of L-
particles/cell reduced the rate of virus adsorption and
also resulted in plateau values after 60 min, suggesting
that the majority of HSV-1 binding sites were occupied.
These results are in good agreement with those given
above for HSV-1 plaquing efficiency.
The effect of L-particles on HSV-1 penetration is
shown in Fig. 1B. Up to 1,000 L-particles/cell had no
effect upon penetration by prebound virions; however,
10,000 reduced the number of virions penetrating the
cells within 60 min to 45% of the control value. The rate
of virus penetration over the first 15 min was slightly
reduced and thereafter reached a plateau, suggesting
that crowding of adsorbed particles (virion or L-particles)
to neighboring sites can slow or even block subsequent
penetration or impair virion replication. For this reason all
subsequent experiments with virions employed less than
10,000 L-particles/cell.
The effect of HSV-1 L-particles on virion replication
It has been suggested that HSV-1 L-particles might
facilitate HSV-1 infection by supplementing the amounts
FIG. 1. The effect of HSV-1 L-particle number on the adsorption (A) and penetration (B) of purified HSV-1 virions. L-particles/cell: none (E), one (),
10 (F), 100 (h), 1000 (n), or 10000 ().
380 DARGAN AND SUBAK-SHARPE
of virion tegument proteins with some role in initiation of
virus replication (McLauchlan et al., 1992). This would
lead to the expectation that virus replication would be
accelerated, reducing the length of the virus replication
cycle, and/or reaching a higher plateau value, through
rescue of some genomes which otherwise might not be
able to initiate productive infection.
Figure 2A shows that L-particles had no detectable
effect on the single-step growth kinetics of HSV-1 grown
in resting or nonresting BHK cells treated with up to 1,000
L-particles/cell. The m.o.i. of 5 PFU/cell used and the
particle:PFU ratio (20:1) of the virus stock, resulted in
each cell being exposed, on average, to 100 virus parti-
cles. The additional tegument proteins contributed by
‘‘noninfectious virus particles’’ could have masked any
effect of L-particle proteins. To eliminate this possibility
and investigate whether pretreatment with HSV-1 L-par-
ticles promoted an enhanced rate of virus replication
upon subsequent infection, resting and nonresting BHK
cells were infected at 0.001 and 0.01 PFU/cell, respec-
tively (Fig. 2B). The 10-fold reduction in m.o.i. for resting
cells increased the number of rounds of replication,
extending the growth cycle in the experiment. These
m.o.i. ensured that each culture received only a single
‘‘noninfectious virus particle’’ for each of 50 resting or 5
nonresting cells allowing any contribution made by teg-
ument proteins of these ‘‘noninfectious virions’’ to be
eliminated.
Supplementing with L-particles, even at 1000/cell, had
no detectable effect on the multistep growth kinetics of
HSV-1 in resting or nonresting cells (Fig. 2B). Similar
results were obtained in additional experiments where
L-particles were increased to 2000/cell and m.o.i. was 1
or 3 PFU/cell (data not shown). These results suggest
that L-particles do not facilitate infection by wild-type
(WT) HSV-1 virions, at least in cultured BHK cells.
The effect of HSV-1 L-particles on the infectivity of
transfected virus DNA
We then investigated the effect of HSV-1 L-particles on
the infectivity of transfected naked HSV-1 DNA. Using
24-well tissue culture trays, duplicate monolayers of BHK
cells (4 3 105 cells/well) were treated with 0, 1, 10, 100,
1,000 or 10,000 L-particles/cell, either 2 h before or 5 h
after calcium phosphate transfection with 0.1–0.2 mg WT
HSV-1 DNA per well. The treated monolayers overlaid
with EC 5% containing 1.25% methyl-cellulose were incu-
bated at 37°C for 2 days then fixed, stained, and plaques
counted.
FIG. 2. The effect of HSV-1 L-particle number on the single-cycle (A) and multicycle (B) growth kinetics of HSV-1 in resting and nonresting BHK cell
cultures infected with purified virions. L-particles/cell: none (F), 5 (n), 100 (E), 1000 (h). In both (A) and (B) the upper set of curves are from nonresting
cell cultures and the lower set of curves are from resting cell cultures.
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Treatment of transfected monolayers with one L-particle/
cell had little or no effect, but 10, 100, 1,000 or 10,000
progressively increased the numbers of plaques produced,
reaching a plateau value with 1000 giving a five- to sixfold
improvement in the plaquing efficiency of the transfected
DNA (Table 1). L-particle treatment before, or after, DNA
transfection gave similar results. In extensive further exper-
iments the enhancement varied between 2.5- and 8.1-fold.
Calcium phosphate and lipofection DNA transfection meth-
ods gave similar results (data not shown).
We then investigated whether the increase in the num-
bers of HSV-1 plaques was merely due to genetic material
present in virions that contaminate the L-particle prepara-
tions (through repair of UV inactivated virion DNA) or
whether L-particle coinfection per se enhanced the number
of productive infections in the population of cells containing
transfected HSV-1 DNA molecules. BHK cell monolayers
were treated with 0, 10, 100, 1000, or 5000 L-particles/cell
and then calcium phosphate-transfected with either WT
HSV-1 DNA or with DNA from the HSV-1 temperature-
sensitive mutant, ts1201 (gene UL26; Preston et al., 1983).
Duplicate cultures were then incubated at 31°C (the per-
missive temperature (PT)) or 38.5°C (the nonpermissive
temperature (NPT)) and the resulting plaques scored after 2
days (Figs. 3A and 3B, respectively).
At PT both ts1201 and WT DNA-transfected cell cul-
tures exhibited a 4.0- to 5.0-fold enhancement of plaque
numbers when treated with 100, 1000, or 5000 L-parti-
cles/cell. At NPT the enhancement of WT DNA infectivity
was 4.0- to 4.5-fold while ts1201 DNA-transfected cells
yielded no plaques at all. This demonstrates that the
observed enhancement of DNA infectivity is due to one
or more protein(s) delivered to the cell by L-particles and
not to DNA from virions contaminating the L-particle
preparation.
HSV-1 L-particle components with a role in
enhancement of HSV-1 DNA infectivity
The teguments of both HSV-1 virions and L-particles
contain some proteins with known roles during the initial
stages of infection. To investigate the contribution made
by individual HSV proteins to enhancement of HSV-1
DNA infectivity, we compared the effects obtained with
L-particles made by WT or mutant viruses that make
either a defective protein or have one or more gene
products deleted.
The tegument protein Vmw65K (a-TIF), coded by gene
UL48, was expected to play a major role in the enhance-
ment of HSV-1 DNA infectivity. This protein is required for
the formation of the immediate early (IE) complex of viral
and cellular proteins (Preston et al., 1988), which binds to
consensus TAATGARAT sequences (Gaffney et al., 1985)
found upstream of all HSV-1 IE promoters, resulting in
transinduction of the IE (a) genes (Campbell et al., 1984).
To study the effect of Vmw 65K, L-particles were pro-
duced from the mutant in1814 which has a 12-bp inser-
tion in UL48 that eliminates the transinducing activity of
the protein without affecting its structural role (Ace et al.,
1988; 1989).
Two hours before transfection with WT HSV-1 DNA,
BHK cell monolayers were treated with either in1814 or
WT L-particles at 0, 10, 100, 1000, or 5000/cell. After 2
days incubation at 37°C the cells were fixed, stained,
and the plaques counted (Fig. 4). WT and in1814 L-
particles enhanced the infectivity of WT DNA to different
extents: The former produced a 3.7-fold increase while
in1814 L-particles, though clearly effective, only resulted
in a 1.7-fold enhancement. These results show that the
transinducing activity of Vmw65K accounts for much of
the enhancement of HSV-1 DNA infectivity produced by
WT L-particles—they also indicate that one (or more)
additional L-particle protein(s) has some boosting effect
on DNA infectivity. An experiment using PRV DNA and
HSV-1 WT or in1814 L-particles produced a similar result
(data not shown). Werstuck et al. (1990) reported that the
plaquing efficiency of wild-type HSV-1 DNA was in-
creased 1.5- to 2.5-fold when transfected into a cell line
expressing HSV-1 a-TIF; this different experimental ap-
proach yielded results consistent with our findings.
Other proteins of both virions and L-particles which
might affect the initial stages of infection include:
VP11/12 (UL46) and VP13/14 (UL47) which increase the
efficiency of a-TIF-mediated IE gene expression (Zhang
and McKnight, 1993); the 110K product of the RL2 gene,
a general transcriptional activator of both viral and cel-
lular genes (Quinlan and Knipe, 1985; Gelman and Sil-
verstein, 1985; Everett; 1987, 1988, 1989; Yao and Court-
ney, 1992); the IE transactivating 175K protein product of
the RS1 gene (O’Hare and Hayward, 1985; DeLuca and
Schaffer, 1988; Shepard et al., 1989; Yao and Courtney,
1989; McLauchlan and Rixon, 1992) and the virion host
shut-off protein product of UL41 (Fenwick and Everrett,
1990), which in addition to its well-known host shut-off
function has been reported to complex with Vmw65K in
the virus particle and at late times in infection inhibiting
a-TIF activity (Smibert et al., 1994). We have used L-
TABLE 1
The Effect of HSV-1 L-Particles on the Infectivity of Transfected
HSV-1 DNA
L-particle treatment
L-Particles/cell
0 1 10 100 1000 10000
Before transfection 6 4 21 36 51 46
10 14 29 43 49 49
After transfection 12 14 24 41 56 53
9 17 29 48 56 54
Note. Figures are virus plaque numbers; HSV-1 DNA was transfected
into BHK cells using the calcium phosphate technique and the exper-
iment was performed in duplicate. Control cultures lacking DNA but
treated with L-particles gave no plaques.
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particles from HSV-1 mutants deleted in the above genes
(except for RS1) in transfection experiments.
The effect of treatment of HSV-1 DNA-transfected cells
with L-particles derived from the UL412 mutant (which
lacks vhs function) is shown in Fig. 5. WT L-particles at
5, 50, 500, or 5000/cell resulted in a progressive increase
in plaque numbers, reaching 4.5-fold with 5000 L-parti-
cles/cell. UL41- mutant L-particles also resulted in a
progressive increase in DNA infectivity but at each L-
particle concentration the enhancement achieved was
lower than that achieved with WT L-particles (1.1:1.3-,
1.5:2.2-, 2.4:4.1-, 3.8:4.5-fold enhancements at 5, 50, 500,
and 5000 L-particles/cell, respectively). The data confirm
the observations of McLauchlan et al. (1992) who found
that the vhs protein was functional in L-particles. Clearly
absence of vhs host shut-off activity results in lower
enhancement of DNA infectivity. We infer that host func-
tions, which can be shut-off by vhs, operate to reduce the
probability of a transfected DNA molecule progressing to
productive infection.
Treatment with D47 mutant and D46 mutant L-particles
also resulted in a progressive increase in DNA infectivity
but the enhancement achieved was lower than that ob-
tained with WT L-particles (for example 3.1- and 3.0-fold
and 4.4- and 3.3-fold at 500 and 5000 L-particles/cell,
respectively, compared with 4.1- and 4.5-fold for WT).
When L-particles derived from the D46/47 double delet-
ant were investigated, the enhancement in plaquing ef-
FIG. 3. The effect of wild-type HSV-1 L-particles on the infectivity of wild-type and ts1201 DNAs at permissive (A) and nonpermissive (B)
temperatures. Filled and unfilled columns represent treatment with WT L-particles of cells transfected with DNAs derived from WT and ts1201 viruses,
respectively. Permissive temperature 31°C; nonpermissive temperature 38.5°C. Control cultures treated with WT L-particles in the absence of viral
DNA gave no plaques. With ts 1201 DNA at NPT no plaques were observed either in the control (no L-particles) or with any of the multiplicities up
to 5000 L-particles/cell. Data are averaged from two separate experiments each performed in duplicate. Error bars are shown. At PT (A) and WT at
NPT (B) only, the dotted line at 1.0 indicates the datum level obtained in the absence of L-particles.
383BIOLOGICAL ACTIVITY OF HSV-1 L-PARTICLES
ficiency was greatly reduced at every level compared
with WT L-particles; reaching a plateau at a 2-fold in-
crease with 500 L-particles/cell. Taken together, these
results suggest that the VP11/12 (UL46) and VP13/14
(UL47) proteins are functional in L-particles and that the
role of each in the enhancement of infectivity of trans-
fected HSV-1 DNA can be partially compensated by the
other. Alternatively absence of both gene products may
alter the balance of tegument proteins to an extent that
makes the L-particles less effective.
Up to 500 L-particles/cell prepared from the Vmw 110K
deficient mutants FxE or DL1403 had little or no enhanc-
ing effect on the plaquing efficiencies of transfected
HSV-1 DNAs, but 5000/cell increased the plaquing effi-
ciency 2.1- and 2.4-fold, respectively. These data suggest
the Vmw110K protein associated with L-particles is func-
tional and almost essential for the enhancement of pla-
quing efficiency of transfected HSV-1 DNAs. Only at high
numbers of L-particles/cell (.500) does the presence of
the other proteins override the lack of functional Vmw
110K molecules—possibly by stimulation of Vmw110K
production from some resident genomes.
The HSV-1 (RS1) 175K protein is indispensable, but the
mutant tsK while functioning normally at PT (31°C)
makes a nonfunctional 175K protein at NPT (38.5°C)
(Preston, 1981). We have adapted a standard comple-
mentation assay to check the functional status of the
175K protein, which is known to be present in large
amounts in L-particles (Szilagyi and Cunningham, 1991).
BHK monolayers were infected at NPT with tsK (5 PFU/
cell); After virus absorption cells were washed with pre-
warmed PBS then treated with WT L-particles (0, 10, 100,
1000, or 5000/cell) for 1 h at NTP. The cell layers were
then washed three times with prewarmed PBS, overlaid
with EC 10% at 38.5°C, incubated at NPT for 24 h, then
harvested by scraping into the medium, and sonicating
to release the cell-associated virus. Infectivity was then
titrated at both PT and NPT. We did not detect any
complementation of tsK by the L-particle-associated WT
175K protein, even in cultures treated with 5000 WT
L-particles/cell (data not shown) so this is unlikely to
contribute to enhancement of HSV-1 DNA infectivity.
HSV-1 L-particles and hexamethylene bisacetamide
operate independenly to enhance the infectivity of
HSV-1 DNA
Hexamethylene bisacetamide (HMBA) increases
the plaquing efficiency of transfected HSV-1 DNAs
(McFarlane et al., 1992). To investigate whether HMBA
and L-particles enhance the plaquing efficiency of
transfected HSV-1 DNAs by the same or by different
mechanisms, treatments were given separately and
together. BHK monolayers were treated with WT L-
particles at 500 or 5000/cell for 1 h at 37°C, then given
three washes with PBS, transfected with WT HSV-1
DNA (0.5 mg/plate), and finally overlaid with EC 5%
containing 0, 0.5, 1, 2, or 3 mM HMBA. After 2 days at
37°C the cultures were fixed, stained, and the plaques
counted. Figure 6 shows that 500 or 5000 L-particles/
cell gave a 2- to 2.5-fold increase in plaque numbers
and that, at all points, simultaneous HMBA treatment
resulted in a further apparently additive increase. Ev-
FIG. 5. The effect of HSV-1 L-particles lacking functional copies of
particular proteins on the infectivity of wild-type HSV-1 DNA. Columns
represent treatment with L-particles derived from the viruses indicated.
Data are averaged from two separate experiments each performed in
duplicate. Error bars are shown. The dotted line at 1.0 indicates the
datum level obtained in the absence of L-particles. Control cultures
treated with L-particles in the absence of viral DNA gave no plaques.
FIG. 4. The effect of in1814 L-particles lacking a-TIF activity on the
infectivity of wild-type HSV-1 DNA. Filled and unfilled columns repre-
sent treatment with L-particles derived from WT and in1814 viruses,
respectively. Data are averaged from four separate experiments each
performed in duplicate. Error bars are shown. The dotted line at 1.0
indicates the datum level obtained in the absence of L-particles. Con-
trol cultures treated with L-particles in the absence of viral DNA gave
no plaques.
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idently L-particle and HMBA treatments enhance
HSV-1 DNA infectivity independently, apparently oper-
ating by different mechanisms.
The L-particles of a-herpesviruses enhance the
infectivity of their own DNAs and those of other
family members
We then investigated with PRV, EHV-1, and HSV-1
whether the L-particles of different a-herpesviruses can
similarly increase the plaquing efficiency of their trans-
fected DNAs and whether—and to what extent—heter-
ologous combinations of L-particles and DNAs affect
plaquing efficiency (Fig.7).
Two hours before transfection, BHK monolayers were
treated with 0, 50, 500, or 1000 PRV, EHV-1, or HSV-1
L-particles/cell. After calcium phosphate transfection of
the cells with 0.5 mg/layer of the respective DNAs the
layers were overlaid with EC 5% plus 1.25% methylcellu-
lose and incubated at 37°C for 2 days, then fixed,
stained, and the plaques counted. Nontransfected con-
trol cultures treated with 1000 PRV, EHV-1, and HSV-1
L-particles/cell gave no virus plaques.
All the L-particle preparations were functional both in
homologous and in heterologous combination: PRV L-
FIG. 6. The effect of HSV-1 L-particles and HMBA treatments alone,
or in combination, on the infectivity of HSV-1 DNA. L-particles/cell; none
(F), 500 (n), or 5000 (h).
FIG. 7. The enhancement of PRV DNA (A), EHV-1 DNA (B), and HSV-1 DNA (C) infectivity produced by treatment of transfected cells with PRV, EHV-1,
and HSV-1 L-particles. Columns are (1) PRV (lightly filled); (2) EHV-1 (unfilled); and (3) HSV-1 (heavily filled) L-particles. Data are from a single
experiment performed in duplicate. The dotted line at 1.0 indicates the datum level obtained in the absence of L-particles. In (A), (B), and (C) 1 5 40,
31, and 45 plaques, respectively.
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particles were least effective producing an increase of
2.6-fold with PRV DNA, 1.9-fold with EHV-1 DNA, and only
1.4-fold with HSV-1 DNA. EHV-1 L-particles produced
2.0-fold (PRV DNA), 2.3-fold (EHV-1 DNA), and 2.0-fold
(HSV-1 DNA) increases of transfection efficiency, while
HSV-1 L-particles were the most effective yielding 3.5-
fold (PRV DNA), 3.9-fold (EHV-1 DNA), and 3.4-fold (HSV-1
DNA) enhancement.
It is tempting to speculate that the greater effective-
ness of HSV-1 L-particles may relate to the HSV-1 Vmw
65K (a-TIF) protein, while the equivalent PRV and EHV-1
gene products have no transinducing function. But this
needs further and more extensive study as do the PRV
and EHV-1 L-particle proteins that enhance the efficiency
of DNA transfection.
We conclude that a-herpesvirus L-particles can deliver
proteins to infected cells that can enhance the plaquing
efficiency of not only their own DNA but also of heterol-
ogous a-herpesvirus DNAs. As the HSV-1 L-particles
were more effective than the homologous combination of
PRV and EHV-1 it seems that they contain one or more
proteins with additional function—perhaps the a-
TIF—or increased amounts of common function proteins
involved in pushing the heterologous a-herpesvirus DNA
into the lytic cycle.
DISCUSSION
We have extended the biological characterization of
HSV-1 L-particles. While L-particles did not detectably
affect the viability of BHK cells they did, when present in
high numbers per cell, affect the rate of subsequent cell
growth. The responsible protein(s) has not been identi-
fied but the activity of the vhs protein is a strong candi-
date.
The L-particle effect on virus adsorption and penetra-
tion can explain the observed reduction in plaquing effi-
ciency of purified HSV-1 virions. HSV-1 adsorption began
to be affected by 1,000 and penetration by 10,000 L-
particles/cell. These experiments support the view that
virions and HSV-1 L-particles employ the same cellular
receptors for entry into BHK cells and that attachment,
penetration, and delivery of envelope and tegument pro-
teins are the same for both types of particle.
It has been reported that the amounts of Vmw 65K
(a-TIF) and vhs proteins contained within a single virus
particle are insufficient for maximal response in infected
cells (Ace et al., 1989; McLauchlan et al., 1992). Hence
McLauchlan et al. (1992) suggested that L-particles
might play a potentiating role during HSV-1 infection by
providing additional amounts of any tegument protein(s)
present in suboptimal amounts in each virion. The sin-
gle- and multistep growth kinetics of HSV-1 in resting
and nonresting cells treated with increasing numbers of
L-particles/cell yielded no evidence to support this pro-
posal. Maximal response as measured experimentally
may not be needed and the tegument proteins normally
packaged in the virion may be in optimal amounts for
HSV replication. These in vitro data if applicable to the in
vivo situation suggest that L-particles might contribute
very little to HSV infectivity during natural infection; how-
ever, our experiments do not exclude activation of some
‘‘noninfectious’’ virions by coinfecting L-particles.
The UV treatment of our L-particle preparation, needed
to eliminate residual infectivity, could have impaired the
protein(s) required to enhance HSV-1 replication. UV
treatment, however, did not inhibit the function of the
L-particle Vmw 65K (a-TIF), which retained full or nearly
full activity (McLauchlan et al., 1992).
Treatment of cell cultures with HSV-1 L-particles, ei-
ther before or after transfection with HSV-1 DNA, in-
creased the plaquing efficiency of the viral DNA by sev-
eral fold. To identify proteins involved, we investigated
the ability of L-particles made by HSV-1 mutant viruses,
either defective in or deleted for genes, UL41, UL46,
UL47, UL48, RS1, and RL2 (encoding, vhs, VP11/12, VP13/
14, Vmw 65K ( a-TIF), Vmw IE175K, and Vmw 110K, re-
spectively), to enhance the infectivity of transfected viral
DNA.
The role of the Vmw65K (a-TIF) tegument protein in
transinduction of immediate-early gene expression is
well-known (Campbell et al., 1984). As expected in 1814
L-particles lacking transinducing activity were much less
efficient than WT L-particles in enhancing the infectivity
of transfected HSV-1 DNA. Interestingly, HSV-1 a-TIF sim-
ilarly enhances with heterologous DNA combinations.
Our data show that the L-particle associated VP11/12
and VP13/14 proteins are functional and, surprisingly, the
role of each in enhancement of transfected DNA infec-
tivity can be partially, or completely, compensated by
presence of the other.
UL41 (vhs) activity is also important, but in a different
way—our results imply that unidentified host functions,
usually shut down by vhs activity impair transfected DNA
molecules from progressing to productive infection.
L-particles lacking a functional copy of the Vmw110K
protein were much less effective than WT L-particles in
increasing the infectivity of transfected HSV-1 DNA and
only boosted infectivity at multiplicities greater than 500/
cell. This indicates that Vmw 110K is a most important
L-particle protein, active in enhancing transfected DNA
infectivity. Only at very high concentrations of L-particles,
with nonfunctional Vmw110K, can the enhancing effect of
other L-particle proteins be detected.
Failure to detect complementation between tsK and
WT L-particles suggests that the L-particle-associated
Vmw175K (RS1) protein is present either in a nonfunc-
tional conformation or in insufficient amounts or is inef-
ficiently transported to the nucleus of cells.
The L-particles produced by HSV-1, PRV, and EHV-1
increase the plaquing efficiency of their own DNAs, sug-
gesting that enhancement will apply to all a-herpesvi-
386 DARGAN AND SUBAK-SHARPE
ruses. L-particles may therefore have some importance
in early virus replication, particularly under suboptimal
virus growth conditions. When HSV-1, PRV, and EHV-1
L-particles were employed in all heterologous combina-
tions with their transfected DNAs enhancement of infec-
tivity was found. We conclude that a-herpesviruses in-
corporate into their L-particles proteins capable of
inducing the lytic cycle from nonreplicating homologous
or heterologous DNA molecules within transfected cells.
Interestingly, treatment of PRV, EHV-1, or HSV-1 DNA-
transfected cells with HSV-1 L-particles consistently
yielded the greatest increase in DNA infectivity. We infer
that analogues of most or all HSV-1 L-particle proteins
with a role in enhancement of HSV DNA infectivity will
also be important for enhancement of the plaquing effi-
ciency of PRV and EHV-1 DNAs.
The finding that HSV-1 L-particle treatment of trans-
fected cells results in lytic replication from, what would
otherwise be quiescent transfected genomes, suggests
that L-particles may have a role in vivo to favor success-
ful initiation of virus growth, where viral DNA is present
in a cell under suboptimal replication conditions.
The role, if any, of HSV-1 L-particles in human infection
remains to be determined. While particles morphologi-
cally resembling HSV-1 L-particles have been observed
in vesicular fluid from cold sores (our unpublished ob-
servations), low numbers have precluded unambiguous
identification by physical and biochemical characteriza-
tion. Further study is needed to resolve the role, if any,
played by HSV-1 L-particles during natural infection.
We do not believe that L-particles represent a byprod-
uct of HSV replication with no biological significance as
several pieces of evidence point to the intrinsic impor-
tance of L-particles: First, virus-related particles, analo-
gous to HSV-1 L-particles have been isolated from all
a-herpesviruses so far examined. Second, production of
L-particles by diverse a-herpesviruses is not restricted to
a single cell line, or cell type, or to cells derived from a
single animal species. Third, the ratio of L-particles to
virions is maintained in those combinations that we have
tested at about 1:1, irrespective of the virus/cell system
studied (our unpublished observations), although in
some other systems this is not the case (Yang and
Courtney et al., 1995). Finally, Rixon et al. (1992) have
shown that L-particles are not produced due to loss of
the nucleocapsid from virions, nor can L-particle produc-
tion be explained by aberrant particle synthesis occur-
ring late in infection, as L-particles are made concur-
rently with virion particles from the earliest times after
infection.
These various observations point to some selectively
advantageous role for L-particles in HSV-1 infection: they
might act as decoys for the immune system, reducing
antibody effectiveness at the time of infection; they might
have a role in vivo in enhancing reactivation from latency;
they might play a facilitating role in promoting infection of
some semipermissive cell types; or they might increase
the probability of infection by partially inactivated coin-
fecting virions.
Further study will not only resolve the role of L-parti-
cles in a-herpesvirus infection, but will also provide in-
formation on the function of individual tegument proteins
which in L-particle-treated cells can be isolated from the
complications resulting from viral replication.
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